Alabaster VA et al. |
UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo. |
1991 |
Agents Actions Suppl. |
pmid:1793066
|
Heuer HO |
The effects of hetrazepine PAF antagonists in preclinical models of asthma. |
1991 |
Agents Actions Suppl. |
pmid:1793067
|
Mazzoni L et al. |
Changes in airway sensitivity to histamine are not necessarily paralleled by changed sensitivity to acetylcholine. |
1991 |
Agents Actions Suppl. |
pmid:1793069
|
Billah MM et al. |
Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine. |
1991 |
Agents Actions Suppl. |
pmid:1793070
|
Saeed SA et al. |
Inhibitory effect of oral ketotifen on ex vivo platelet activating factor-induced platelet aggregation. |
1991 |
Agents Actions Suppl. |
pmid:1793071
|
Hoshiko K et al. |
Histamine(H1) antagonists and airway hyperreactivity in the guinea-pig. |
1991 |
Agents Actions Suppl. |
pmid:1686527
|
Mest HJ et al. |
Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats. |
1992 |
Agents Actions Suppl. |
pmid:1632298
|
Koltai M and Braquet PG |
Involvement of PAF in atherogenesis. Brief review. |
1992 |
Agents Actions Suppl. |
pmid:1632308
|
McMillan RM and Carter GW |
Design and development of drugs. |
1991 |
Agents Actions Suppl. |
pmid:1664186
|
Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
Page CP and Spina D |
The therapeutic relevance of PAF antagonists. |
1989 |
Agents Actions Suppl. |
pmid:2683635
|
Rink TJ |
Stimulus-response coupling mechanisms in human platelets. |
1986 |
Agents Actions Suppl. |
pmid:3028101
|
Baroggi N et al. |
Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. |
1986 |
Agents Actions Suppl. |
pmid:3028108
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Muirhead EE |
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. |
1987 |
Agents Actions Suppl. |
pmid:3324720
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
Guinot P et al. |
Effects of BN 52063 on PAF-acether induced weal and flare in man. |
1987 |
Agents Actions Suppl. |
pmid:3479000
|
Lang M et al. |
Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. |
1987 |
Agents Actions Suppl. |
pmid:3479001
|
Codde JP et al. |
Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. |
1987 |
Agents Actions Suppl. |
pmid:3481207
|
Braquet P et al. |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. |
1987 |
Agents Actions Suppl. |
pmid:3314418
|
Morley J et al. |
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. |
1988 |
Agents Actions Suppl. |
pmid:3262989
|
Subissi A and Criscuoli M |
Effects of LG 30435 on different platelet activating factor-induced responses. |
1988 |
Agents Actions Suppl. |
pmid:3262990
|
Heuer H and Casals-Stenzel J |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. |
1988 |
Agents Actions Suppl. |
pmid:3262991
|
Anderson GP and Fennessy MR |
Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. |
1988 |
Agents Actions Suppl. |
pmid:3140616
|
Bertrand C et al. |
Selective implication of thromboxane A2 and PAF-acether in two guinea pig anaphylactic models. |
1990 |
Agents Actions Suppl. |
pmid:2080755
|
Tsunoda H et al. |
Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses. |
1990 |
Agents Actions Suppl. |
pmid:2080757
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
Vargaftig BB |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. |
1983 |
Agents Actions Suppl. |
pmid:6575594
|
Page CP et al. |
PAF-acether: a putative mediator of asthma and inflammation. |
1983 |
Agents Actions Suppl. |
pmid:6575595
|
Northover AM |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro. |
1990 |
Agents Actions |
pmid:2111079
|
McLeod J et al. |
Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. |
1990 |
Agents Actions |
pmid:1695435
|
Adolfs MJ et al. |
PAF-acether modifies human peritoneal macrophage cAMP levels in a biphasic fashion. |
1989 |
Agents Actions |
pmid:2540635
|
Bekemeier H and Sänze JU |
Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. |
1989 |
Agents Actions |
pmid:2476918
|
Jouquey S et al. |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. |
1988 |
Agents Actions |
pmid:2459935
|
Sanchez Crespo M and Nieto ML |
Modulation of PAF biosynthesis in human polymorphonuclear leukocytes. The role of phorbol esters and protein kinases. |
1989 |
Agents Actions |
pmid:2711927
|
Zijlstra FJ et al. |
The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. |
1989 |
Agents Actions |
pmid:2711928
|
Nijkamp FP et al. |
Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. |
1989 |
Agents Actions |
pmid:2711929
|
Oliver JL et al. |
Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. |
1989 |
Agents Actions |
pmid:2711930
|
Nieminen MM et al. |
Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit. |
1991 |
Agents Actions |
pmid:1862740
|
Jenei B et al. |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). |
1991 |
Agents Actions |
pmid:1862750
|
Kantar A et al. |
Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study. |
1991 |
Agents Actions |
pmid:1862752
|
Carlson RP et al. |
Pharmacologic modulation of PAF-induced mortality in mice. |
1987 |
Agents Actions |
pmid:3120513
|
Anderson GP et al. |
Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. |
1988 |
Agents Actions |
pmid:3136622
|
Taira M et al. |
Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. |
1988 |
Agents Actions |
pmid:3407549
|
Kusner EJ et al. |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. |
1987 |
Agents Actions |
pmid:3577957
|
Northover AM |
In vitro effects of PAF on venous endothelial cell actin disposition. |
1992 |
Agents Actions |
pmid:1509977
|
Benveniste J |
Platelet-activating factor (PAF-acether): present status. |
1981 |
Agents Actions |
pmid:6176101
|
Meats JE et al. |
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. |
1993 |
Agents Actions |
pmid:8273553
|
Thomas TK et al. |
Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. |
1993 |
Agents Actions |
pmid:8273566
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|